TP53 and kidney disorder: The p53 inhibitor pifithrin-α (PIF) attenuates the fraction of G2/M-arrested epithelial cells while deletion of cyclin G1, mTOR, LC3, or lysosomal associated membrane protein 2 (LAMP2) reduces the onset and progression of renal disease (Canaud et al., 2019).